Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Sanofi source : Www.precisionbiosciences.com save search
Preliminary Safety and Efficacy of PBCAR0191, an Allogeneic ‘Off-the-Shelf’ CD19-Directed CAR-T for Patients with Relapsed/Refractory (R/R) CD19+ B-ALL
Published: 2022-01-07 (Crawled : 19:00) - precisionbiosciences.com
SNYNF | News | $94.25 1.67% -2.18% 480
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
| Email alert
Add to watchlist
DTIL | $10.23 5.68% 6.29% 29K
|
Health Technology
| Email alert
Add to watchlist
pbcar0191 car-t
Allogeneic CAR-T PBCAR0191 with Intensified Lymphodepletion is Highly Active in Subjects with Relapsed/Refractory B-Cell Malignancies
Published: 2022-01-07 (Crawled : 19:00) - precisionbiosciences.com
SNYNF | News | $94.25 1.67% -2.18% 480
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
| Email alert
Add to watchlist
DTIL | $10.23 5.68% 6.29% 29K
|
Health Technology
| Email alert
Add to watchlist
pbcar0191 car-t cel t-cell
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 26M
|
AGBA | $2.97 137.6% 57.48% 66M
|
Finance
EDBL | News | $6.59 75.27% 41.8% 2M
|
ZAPP | $4.44 50.2% 33.12% 370K
|
n/a
MTC | $2.24 43.59% 30.67% 6M
|
Technology Services
OPRT | News | $3.15 40.0% 29.13% 12M
|
Finance
SHIM | $3.045 35.33% 26.23% 870K
|
HKIT | $1.33 30.39% 24.16% 390K
|
Technology Services
ABVC | $1.35 29.81% 23.53% 7.1M
|
Wholesale Trade
OST | $0.5 25.0% 21.88% 280K
|
Your saved searches
Save your searches and get alerts when important news are released.